foundayo vs oral semaglutide mechanism
5 Physiological Reasons Foundayo Slams Oral Semaglutide
Foundayo outperforms oral semaglutide because its dual GLP-1/GIP agonism attacks obesity at multiple physiological nodes, not just appetite. The drug’s broader hormonal reach explains the larger weight reductions seen in recent trials, while oral semaglutide relies on a single receptor pathway. Medical Disclaimer: This article is for informational